XML 12 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2018
Dec. 31, 2017
Assets:    
Cash and cash equivalents $ 22,174 $ 20,214
Investments in securities:    
Fixed maturities, available-for-sale, at fair value (amortized cost: March 31, 2018: $99,023; December 31, 2017: $100,314) 100,389 103,341
Equity securities, at fair value (cost: March 31, 2018: $26,530; December 31, 2017: $26,003) 47,252 47,367
Short-term investments 21,144 23,780
Other investments 11,601 12,032
Total investments 180,386 186,520
Premium and fees receivable 9,889 10,031
Accrued interest and dividends 1,359 1,100
Prepaid expenses and other receivables 7,904 7,730
Property, net 10,376 10,173
Goodwill and other intangible assets 11,176 11,357
Other assets 1,417 1,403
Current income taxes receivable 0 385
Total Assets 244,681 248,913
Liabilities:    
Reserve for claims 32,770 34,801
Accounts payable and accrued liabilities 22,876 27,565
Current income taxes payable 215 0
Deferred income taxes, net 8,758 8,626
Total liabilities 64,619 70,992
Commitments and Contingencies
Stockholders' Equity:    
Preferred stock (1,000 authorized shares; no shares issued) 0 0
Common stock – no par value (10,000 authorized shares; 1,887 and 1,886 shares issued and outstanding as of March 31, 2018 and December 31, 2017, respectively, excluding in each period 292 shares of common stock held by the Company) 0 0
Retained earnings 178,971 161,891
Accumulated other comprehensive income 1,009 15,945
Total stockholders’ equity attributable to the Company 179,980 177,836
Noncontrolling interests 82 85
Total stockholders' equity 180,062 177,921
Total Liabilities and Stockholders’ Equity $ 244,681 $ 248,913